Vincerx Pharma, Inc. - Common Stock (VINC)

CUSIP: 92731L106

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / Common Stock
Total 13F shares
16,279,025
Share change
+885,274
Total reported value
$65,122,000
Price per share
$4.00
Number of holders
65
Value change
-$3,570,679
Number of buys
31
Number of sells
19

Quarterly Holders Quick Answers

What is CUSIP 92731L106?
CUSIP 92731L106 identifies VINC - Vincerx Pharma, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Vincerx Pharma, Inc. - Common Stock (VINC) as of Q1 2022

As of 31 Mar 2022, Vincerx Pharma, Inc. - Common Stock (VINC) was held by 65 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 16,279,025 shares. The largest 10 holders included Rubric Capital Management LP, SAGE RHINO CAPITAL LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Affinity Asset Advisors, LLC, TANG CAPITAL MANAGEMENT LLC, Rock Springs Capital Management LP, BlackRock Inc., Holocene Advisors, LP, SPHERA FUNDS MANAGEMENT LTD., and VANGUARD GROUP INC. This page lists 65 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.